Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.42 |
| ▸ | P2RX4 | Q99571 | 12/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16604412 | 0.85 | MGLL (0.50) | AHRP2RX4ALOX5MGLLP2RX1 | |
| SCHEMBL29829444 | 0.85 | MGLL (0.50) | AHRP2RX4ALOX5MGLLP2RX1 | |
| SCHEMBL24528515 | 0.82 | P2RX4 (0.43) | AHRP2RX4 | |
| SCHEMBL19037723 | 0.77 | AHR (0.37) | AHRP2RX4ALOX5MAPTSMN1; SMN2 | |
| SCHEMBL19038786 | 0.77 | AHR (0.50) | AHRP2RX4ALOX5MAPTSMN1; SMN2 | |
| SCHEMBL28420664 | 0.77 | HTR6 (0.44) | AHRP2RX4ALOX5MGLL | |
| SCHEMBL18875290 | 0.77 | TDP1 (0.54) | P2RX4ALOX5MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL29825148 | 0.76 | AHR (0.48) | AHRP2RX4ALOX5MAPTSMN1; SMN2 | |
| SCHEMBL14482242 | 0.76 | AHR (0.44) | AHRP2RX4ALOX5MAPTSMN1; SMN2 | |
| SCHEMBL30560693 | 0.76 | AHR (0.44) | AHRP2RX4ALOX5MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023284103-A1 | ORGANIC COMPOUND AND APPLICATION THEREOF | 清华大学 | 2023-01-19 | — | — | WO | disclosed |